The global POC molecular diagnostics market is projected to grow at a CAGR of 14.7%.
The global point of care POC molecular diagnostics market is expected to reach USD 1440.2 million by 2023 from USD 725.5 million in 2018, at a CAGR of 14.7%. Growth in the POC molecular diagnostics market is driven by the increasing prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIAwaived molecular POC tests. However, inadequate reimbursement and stringent regulatory policies are likely to restrain the growth of this market during the forecast period.
The INAAT technology is expected to grow at highest CAGR during the forecast period.
Based on technology, the POC molecular diagnostics market is segmented into RTPCR, INAAT, and other technologies. The INAAT segment is expected to grow at highest CAGR during the forecasted period. The increasing popularity of INAAT for infectious diseases diagnosis is expected to drive this market in the coming years.
Asia Pacific is projected to grow at the highest CAGR during the forecast period.
While North America is expected to account for the largest share of the global POC molecular diagnostics market, Asia Pacific is projected to grow at the highest CAGR during the study period. The key factors influencing the growth of this market include growing initiatives by market players, rising demand for influenza A/B tests, decentralized healthcare delivery systems, and increasing patient population base in this region.
Breakup profile of primaries:
By Company Type Tier 40%, Tier 30%, and Tier 30%
By DesignationClevel27%, Dlevel18%, and Others55%
By RegionNorth America50%, Europe20%, Asia Pacific20%, and RoW10%
The key players in the global POC molecular diagnostics market are Roche Diagnostics Switzerland, Abbott Laboratories US, Danaher US, Biomerieux France, and Meridian Biosciences US
Research Coverage:
The POC molecular diagnostics market in this report is segmented by product service, application, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches approvals, acquisition, collaborations, agreements, partnerships, and expansion, and profiles key players and their core competencies in the POC molecular diagnostics market.
Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on portfolios offered by the top players in the global POC molecular diagnostics market. The report analyzes the market by product service, application type, technology, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research development activities, and product launches in the global POC molecular diagnostics market
Market Development: Comprehensive information about lucrative emerging marketsthe report analyzes the markets for POC molecular diagnostic products across regions
Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global POC molecular diagnostics market
Competitive Assessment: Indepth assessment of strategies, products, and manufacturing capabilities of the key players in the global POC molecular diagnostics market